Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Timapiprant is a DP2 receptor antagonist (Ki = 0.013 µM).1 It is selective for DP2 over the additional prostanoid receptors DP1, TP, EP1-4, FP, and IP (Kis = >10 µM for all). Timapiprant inhibits calcium mobilization induced by prostaglandin D2 (PGD2; Item No. 12010) in CHO cells expressing human DP2 (IC50 = 0.028 µM). It inhibits PGD2-induced Th2 T helper cell chemotaxis, IL-13 production, and apoptosis (IC50s = 0.028, 0.019, and 0.035 µM, respectively). In vivo, timapiprant reduces PGD2-induced blood eosinophilia in rats (ED50 = 0.04 mg/kg) and pulmonary eosinophil accumulation in guinea pigs (ED50 = 0.01 mg/kg). It also reduces amyloid-β (Aβ) plaque area and hippocampal microglial accumulation and improves learning and memory deficits in the TgF344 transgenic rat model of age-dependent and progressive Alzheimer’s disease.2
WARNING This product is not for human or veterinary use.
1. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-
2. Timapiprant, a prostaglandin D2 receptor antagonist, ameliorates pathology in a rat Alzheimer’s model. Life Sci. Alliance 5(12), e202201555 (2022).